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Summary
 
Bacterial lipopolysaccharide (LPS) induces activation of the transcription factor nuclear factor
 
k
 
B (NF-
 
k
 
B) in host cells upon infection. LPS binds to the glycosylphosphatidylinositol (GPI)-
anchored membrane protein CD14, which lacks an intracellular signaling domain. Here we in-
vestigated the role of mammalian Toll-like receptors (TLRs) as signal transducers for LPS.
Overexpression of TLR2, but not TLR1, TLR4, or CD14 conferred LPS inducibility of NF-
 
k
 
B activation in mammalian 293 cells. Mutational analysis demonstrated that this LPS response
requires the intracellular domain of TLR2. LPS signaling through TLR2 was dependent on se-
rum which contains soluble CD14 (sCD14). Coexpression of CD14 synergistically enhanced
LPS signal transmission through TLR2. In addition, purified recombinant sCD14 could substi-
tute for serum to support LPS-induced TLR2 activation. LPS stimulation of TLR2 initiated an
interleukin 1 receptor–like NF-
 
k
 
B signaling cascade. These findings suggest that TLR2 may be
a signaling component of a cellular receptor for LPS.
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acterial LPS (also known as endotoxin), a constituent
of the outer membrane of the cell wall of Gram-nega-
tive bacteria, is one of the main causative agents of septic
shock in humans (1, 2). Recognition of LPS is a key event
in host antimicrobial defense reactions (1, 2). LPS is a com-
plex glycolipid composed of a hydrophilic polysaccharide
portion and a hydrophobic domain known as lipid A (1).
The conserved lipid A structure has been identified as the
LPS component responsible for LPS-induced biological ef-
fects (1). LPS elicits its responses through stimulation of
host cells such as monocytes and macrophages to produce
and release endogenous mediators including the proinflam-
matory cytokines IL-1, IL-6, and TNF (1). 
LPS-induced signal transmission is thought to entail its
binding to specific cellular receptors, which trigger intra-
cellular signaling cascades leading to activation of the tran-
scription factor nuclear factor 
 
k
 
B (NF-
 
k
 
B)
 
1
 
 and p38 mito-
gen-activated protein kinases (MAP kinases), among others
(2). The 55-kd glycoprotein CD14 binds LPS with high
affinity and is involved in mediating LPS responses (1, 2).
Binding of LPS to CD14 requires the serum factor, LPS-
binding protein (LBP), which delivers LPS to CD14-
expressing monocytes/macrophages (1, 2). In CD14
 
2
 
 cells
such as endothelial cells, granulocytes, and lymphocytes,
soluble CD14 (sCD14) found in serum is thought to func-
tionally replace membrane-bound CD14 (1, 2). Since CD14
is a glycosylphosphatidylinositol (GPI)-anchored membrane
protein devoid of a cytoplasmic domain, it presumably does
not elicit intracellular signaling events directly (1, 2). To
date, the identification of a bona fide signal-transducing
component of the putative LPS receptor complex has re-
mained elusive.
The 
 
toll
 
 gene controls dorsoventral pattern formation
during the early embryonic development of 
 
Drosophila mel-
anogaster
 
 (3). Interestingly, 
 
toll
 
 participates in antimicrobial
immune responses upon infection in adult 
 
Drosophila 
 
(4).
The Toll protein is a transmembrane receptor that displays
resemblance in its intracellular portion to the signaling
domains of members of the IL-1R family which mediate
activation of NF-
 
k
 
B (3). Indeed, Toll initiates a signaling
cascade homologous to mammalian NF-
 
k
 
B activation
pathways (3).
Recently, several members of a mammalian Toll-like re-
ceptor (TLR) family have been identified (5–8). In addi-
tion to homology within their cytoplasmic domains, both
 
1
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k
 
B; NIK, NF-
 
k
 
B–inducing kinase; RT, reverse transcription; sCD14, soluble CD14;
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mammalian and 
 
Drosophila 
 
Toll receptors share a character-
istic repeating leucine-rich motif in their extracellular re-
gions. Similar to IL-1Rs and 
 
Drosophila
 
 Toll, several TLRs
have been shown to signal through the NF-
 
k
 
B pathway (6,
8). In particular, functional analysis of TLR4 (also desig-
nated hToll) demonstrated that it is capable of inducing the
expression of NF-
 
k
 
B–controlled genes for the inflamma-
tory cytokines IL-1, IL-6, and IL-8, as well as expression of
the costimulatory molecule B7.1, which is required for the
activation of naive T cells (6). These findings provided evi-
dence that TLR4 functions in vertebrates as a nonclonal re-
ceptor of the innate immune system that signals activation
of adaptive immunity (6). To further investigate a con-
served function for TLRs in innate immune responses, we
examined if mammalian members of this receptor family
might be involved in LPS signal transduction.
 
Materials and Methods
 
Cell Culture and Biological Reagents.
 
A subclone of the human
embryonic 293 cell line has been maintained at Tularik, Inc., since
1993 as described (9). Mono-Mac-6 cells were licensed from Dr.
H.W.L. Ziegler-Heitbrock (University of Munich, Munich, Ger-
many). All other cell lines were obtained directly from the Ameri-
can Type Culture Collection (Rockville, MD). Tissue culture ex-
periments were performed in the presence of 10% certified fetal
bovine serum (GIBCO BRL, Gaithersburg, MD) unless otherwise
stated. The serum was not heat inactivated and contained endotoxin
at 
 
,
 
10 EU/ml as specified by the manufacturer. For stimulation of
tissue culture cells, LPS from 
 
Escherichia coli
 
 serotype 0111:B4 pre-
pared by phenol extraction was purchased from Sigma Chemical
Co. (St. Louis, MO). Further purification of LPS by ion exchange
chromatography or gel filtration (Sigma Chemical Co.) had no ef-
fect on the biological activity. Similar results were obtained with
LPS preparations from various other 
 
E. coli
 
 strains as well as from
 
Salmonella minnesota, Salmonella typhimurium
 
, and 
 
Shigella flexneri
 
 ob-
tained from Sigma Chemical Co., Difco Laboratories, Inc. (Detroit,
MI), or List Biological Laboratories, Inc. (Campbell, CA). Lipid A
from 
 
E. coli
 
 K12 D31m4 LPS was from List Biological Laboratories,
Inc. Recombinant human TNF-
 
a
 
 and IL-1
 
b
 
 were provided by
Genentech Inc. (South San Francisco, CA). Anti-Flag epitope mAb
M2 was from Eastman Kodak Co. (New Haven, CT) and anti-
CD14 mAb MEM18 from Caltag Laboratories (Burlingame, CA).
Rabbit anti-Flag polyclonal antibodies were purchased from Santa
Cruz Biotechnology, Inc. (Santa Cruz, CA). Rabbit polyclonal an-
tibodies against human CD14 were raised against a 33-mer peptide,
VEVEIHAGGLNLEPFLKRVDADADPRQYADTVK, by Berke-
ley Antibody Company (Richmond, CA).
 
Expression Plasmids.
 
The coding region of human CD14 was
amplified by reverse transcription (RT)-PCR from mRNA
isolated from THP-1 cells and inserted into the mammalian ex-
pression plasmid pRK (10), downstream of the CMV immediate-
early promoter and enhancer. The coding regions of TLR1,
TLR2, and TLR4 minus the respective NH
 
2
 
-terminal signal se-
quences were amplified by PCR from a human leukocyte cDNA
library (Clontech, Palo Alto, CA) and cloned into the expression
vector pFlag-CMV-1 (Eastman Kodak Co.), in which the
preprotrypsin leader precedes an NH
 
2
 
-terminal Flag epitope.
Epitope tagging had no influence on the activity of TLRs in tissue
culture. Expression plasmids for TLR2 truncation mutants were
generated by subcloning PCR-amplified TLR2 cDNA fragments.
 
NF-
 
k
 
B Reporter Assay.
 
Human embryonic kidney 293 cells
(3 
 
3 
 
10
 
5
 
) were plated in 3.5-cm dishes and transfected on the fol-
lowing day by the calcium phosphate precipitation method (11,
12) with the indicated amounts of expression vectors and 0.1 
 
m
 
g
ELAM-1 luciferase reporter plasmid (13). The cells were lysed for
measurement of luciferase activity using reagents from Promega
Corp. (Madison, WI). An RSV-
 
b
 
-galactosidase control plasmid
(1 
 
m
 
g) was used for normalizing transfection efficiencies. All bar
diagrams are shown as mean 
 
6
 
 SEM for one representative ex-
periment in which each transfection was performed in duplicate.
Each experiment was repeated at least twice in all cases.
 
Electrophoretic Mobility Shift Assay.
 
293 cell clones stably ex-
pressing Flag epitope–tagged TLRs or CD14 were generated by
selection with G418 (GIBCO BRL) and subsequent FACS
 
Ò
 
analysis as described (14). Nuclear extracts from 2 
 
3 
 
10
 
6
 
 cells
were prepared (15) and analyzed for NF-
 
k
 
B DNA-binding activ-
ity with a radiolabeled double-stranded oligonucleotide contain-
ing two NF-
 
k
 
B binding sites (15).
 
Immunoprecipitation and Immunoblotting.
 
For the detection of
transiently overexpressed CD14 and TLRs, 4 
 
m
 
g of expression
plasmids was transfected into 293 cells (3 
 
3 
 
10
 
6
 
) seeded in
100-mm dishes. Total cell lysates were prepared and incubated
with anti-CD14 mAb MEM18 or anti-Flag mAb M2 and protein
G–agarose beads (Oncogene Science, Inc., Manhasset, NY) as
described (12). The immune complexes were washed, fraction-
ated by SDS-PAGE, and transferred to nitrocellulose membrane.
Immunoblot analysis was performed with rabbit polyclonal anti-
bodies against CD14 or the Flag epitope using enhanced chemi-
luminescence detection (Amersham Pharmacia Biotech, Inc., Pis-
cataway, NJ).
 
RT-PCR Analysis.
 
Poly(A)
 
1
 
 RNA was isolated from tissue
culture cells using the Oligotex
 
Ô
 
 Direct mRNA kit (QIAGEN,
Inc., Chatsworth, CA) and treated with RNase-free DNase I
(Roche Molecular Biochemicals, Indianapolis, IN). RT was per-
formed using the SuperScript
 
Ô
 
 Preamplification System (GIBCO
BRL) followed by PCR amplification with 
 
Taq
 
 polymerase
(QIAGEN, Inc.) for 24 cycles at 95
 
8
 
C for 40 s, 54
 
8
 
C for 40 s,
and 72
 
8
 
C for 1 min. PCR primers for TLR2 were 5
 
9
 
-GCC-
AAAGTCTTGATTGATTGG and 5
 
9
 
-TTGAAGTTCTCCAG-
CTCCTG. GAPDH primers were obtained from Clontech.
 
Purification of Recombinant sCD14.
 
The coding region of hu-
man CD14 lacking the COOH-terminal four amino acids was
fused in frame to a COOH-terminal Flag epitope in pRK (10).
For transient expression of sCD14, 293 cells were cultured in se-
rum-free CHO-S-SFM II medium (GIBCO BRL) supplemented
with 10 ng/ml EGF (GIBCO BRL). sCD14 was purified to ho-
mogeneity from tissue culture supernatants by chromatography
with anti-Flag M2 affinity resin (Eastman Kodak Co.) and Flag
peptide elution as described (12).
 
Results
 
Effect of TLRs on LPS-induced NF-
 
k
 
B Activation.
 
We ini-
tially established a tissue culture system suitable for analyz-
ing LPS signaling components. Human embryonic kidney
293 cells were transiently transfected with an NF-
 
k
 
B–
dependent E-selectin (ELAM-1) promoter luciferase reporter
gene (13). No significant induction of reporter gene activ-
ity was observed upon stimulation of transfected cells with
LPS (Fig. 1 
 
A
 
). Similarly, transient as well as stable transfec-
tion of an expression vector for CD14 did not mediate LPS
induction of the reporter gene (Fig. 1 
 
A
 
, and data not 
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shown). This indicates that the examined 293 cells are ei-
ther defective in or express functionally insufficient levels
of one or more components of the LPS signal recognition
and/or signal transduction pathway other than CD14.
We next tested the effect of transiently transfected TLR
expression vectors on NF-
 
k
 
B–dependent reporter gene ac-
tivity. Overexpression of TLR4 constitutively activated the
reporter gene (Fig. 1 
 
A
 
). Similar results had previously been
observed for a mutant TLR4 protein, in which the native
extracellular domain was replaced by the extracellular do-
main of CD4 (6). LPS stimulation did not elicit additional
reporter gene activation by TLR4 (Fig. 1 
 
A
 
). In contrast to
TLR4, overexpression of TLR1 and TLR2 caused only
marginal activation of the reporter gene in unstimulated
cells despite comparable expression levels of all three recep-
tors (Fig. 1, 
 
A 
 
and
 
 B
 
). Although TLR1-expressing cells did
not respond to LPS stimulation, cells expressing TLR2
strongly activated the NF-
 
k
 
B–dependent reporter gene
upon stimulation with LPS (Fig. 1 
 
A
 
). This stimulation oc-
curred in a dose-dependent manner with respect to LPS
concentration (see Fig. 4) and the amount of transiently
transfected TLR2 expression plasmid (data not shown).
LPS-induced reporter gene activity through TLR2 consis-
tently exceeded by three- to fourfold that produced by
TLR4 overexpression (Fig. 1 
 
A
 
).
NF-
 
k
 
B–dependent reporter gene activation by LPS was
also observed in a similar manner in 293 cell clones stably
expressing TLR2 (293-TLR2) but not TLR1 or TLR4
(data not shown). Furthermore, electrophoretic mobility
shift assays (EMSAs) demonstrated that nuclear extracts from
LPS-treated 293-TLR2 cells contained a significant
amount of NF-
 
k
 
B DNA-binding activity (Fig. 1 
 
C
 
). Thus,
overexpression of TLR2 is sufficient to confer LPS induc-
ibility of NF-
 
k
 
B activation in mammalian 293 cells.
 
TLR2-mediated NF-
 
k
 
B Activation by Lipid A.
 
Since the
lipid A portion of LPS is sufficient to induce LPS responses,
we tested the effect of lipid A on TLR2-mediated NF-
 
k
 
B
activation in transient reporter gene assays. Although 293 cells
transfected with empty control vector could not be stimu-
lated with lipid A, TLR2-expressing cells responded to lipid
A in a dose-dependent manner similar to stimulation with
LPS (Fig. 2). Thus, TLR2 overexpression mediates respon-
siveness to the biologically active moiety of LPS, lipid A.
 
Mutational Analysis of TLR2.
 
We next investigated the
contribution of the intracellular domain of TLR2 to LPS-
induced NF-
 
k
 
B activation by mutational analysis. In con-
trast to wild-type TLR2, deletion of the majority of the cy-
toplasmic portion of TLR2 created a mutant TLR2 protein
that was defective in LPS-stimulated NF-
 
k
 
B activation
(Fig. 3). This indicates that TLR2-mediated NF-
 
k
 
B activa-
Figure 1. Effect of CD14 and TLRs on
LPS-induced NF-kB activation. (A) TLR2-
mediated activation of NF-kB by LPS. Lu-
ciferase activities were determined in 293
cells transfected with the indicated expression
plasmids (1 mg) together with ELAM-1 lu-
ciferase reporter plasmid for 24 h, and either
left untreated (white bars) or stimulated with
LPS (10 mg/ml) for 6 h (black bars) before
harvest. (B) Expression of CD14 and TLRs.
293 cells were transiently transfected with al-
iquots from the same transfection mixtures as
in A containing 4 mg of expression plasmid as
described in Materials and Methods. Flag
epitope–tagged TLRs and CD14 were im-
munoprecipitated and detected by immuno-
blotting with anti-Flag antibodies (lanes 1,
3–5; upper panel) and anti-CD14 antibodies
(lanes 1 and 2; lower panel), respectively. (C)
LPS induction of NF-kB DNA-binding ac-
tivity by TLR2. EMSA was performed with
nuclear extracts from 293 cells and cells stably
expressing TLR2 (293-TLR2) that were ei-
ther left untreated (lanes 1 and 4) or stimu-
lated with LPS (10 mg/ml; lanes 2 and 4) or
IL-1 (20 ng/ml; lanes 3 and 6) for 20 min be-
fore harvest.
Figure 2. TLR2-mediated activation of NF-kB by lipid A. 293 cells
were transfected with 200 ng empty control vector (white bars) or TLR2
expression plasmid (black bars) and ELAM-1 luciferase reporter plasmid.
After 24 h, cells were stimulated with the indicated concentrations of LPS
or lipid A for 6 h before determination of luciferase activities.2094 LPS Signaling via Toll-like Receptor 2
tion in response to LPS occurs via an intracellular signaling
cascade initiated at the cytoplasmic domain of TLR2. Subse-
quently, mutant versions of TLR2 were constructed by suc-
cessive COOH-terminal truncation of the receptor cytoplas-
mic domain. Analysis in transient transfection assays revealed
that deletion of the COOH-terminal 15 amino acids of the
cytoplasmic domain of TLR2 was sufficient to abrogate
LPS-induced NF-kB reporter gene activation (Fig. 3). This
mutation precisely eliminates the most COOH-terminal
block of amino acid homology within the cytoplasmic
domains of members of the Toll and IL-1R families (7).
Serum Dependence of LPS Signaling through TLR2. To in-
vestigate the serum dependence of LPS signaling through
TLR2, 293 cells transiently expressing TLR2 were stimu-
lated with LPS over a wide concentration range either in the
presence or absence of serum. When serum was present
reporter gene activation was detected at low LPS doses (Fig.
4). In contrast, in the absence of serum low concentrations of
LPS were ineffective in stimulating reporter gene activity
(Fig. 4). Only at much higher LPS concentrations did
reporter gene activation become apparent under serum-free
conditions (Fig. 4). Overall, the dose response to LPS was
shifted by approximately three orders of magnitude depend-
ing on the serum conditions (Fig. 4). Thus, efficient LPS sig-
nal transmission by TLR2 requires serum components
which presumably include sCD14 and/or LBP. At very high
concentrations of LPS, reporter gene induction was inde-
pendent of serum conditions (Fig. 4). This is in agreement
with observations that responsiveness to LPS at high concen-
trations bypasses the requirement for LBP and CD14 (16).
Role of CD14 in LPS Signaling by TLR2. The effect of
CD14 on LPS signaling through TLR2 was further exam-
ined in transient transfection assays in 293 cells. When
CD14 was coexpressed with TLR2, reporter gene activa-
tion at a low LPS dose was increased by approximately
five- to sevenfold compared with its induction in cells ex-
pressing TLR2 alone (Fig. 5 A). This stimulatory activity of
CD14 decreased at higher LPS concentrations and was un-
detectable at a very high LPS dose (Fig. 5 A). Thus, at low
levels of LPS CD14 exerts a synergistic effect on LPS-
induced signal transduction through TLR2.
We further addressed the contribution of CD14 to
TLR2-mediated LPS signaling by using purified recombi-
nant sCD14. In transient reporter gene assays, sCD14 was
able to substitute dose-dependently for serum in supporting
LPS signaling by TLR2 (Fig. 5 B). This indicates that
CD14 is required for activation of TLR2 at low concentra-
tions of LPS.
Involvement of TNF and IL-1 Signal Transducers in LPS
Signaling by TLR2. To examine the signaling pathway
initiated by TLR2 in response to LPS, we used dominant-
negative versions of components of the NF-kB signaling
cascades for IL-1 and TNF in transient cotransfection assays
in 293 cells. Catalytically inactive mutants of the two IkB
kinases, IKK-a and IKK-b (12, 17–20), as well as the NF-
kB–inducing kinase, NIK (21), inhibited TLR2-mediated
reporter gene activation by LPS similar to IL-1– and TNF-
induced activation (Fig. 6), suggesting that these kinases
represent common components in the respective NF-kB
pathways. TLR2-induced NF-kB activation was not in-
hibited by a dominant-negative mutant of TNF receptor–
associated factor (TRAF)2, which suppresses NF-kB acti-
vation by TNF but not IL-1 in mammalian cells (22; Fig.
6). Conversely, a dominant-negative version of TRAF6,
which inhibits NF-kB activation by IL-1 but not TNF
(22), also suppressed NF-kB activation by TLR2 (Fig. 6).
In addition, a truncated version of MyD88, a constituent of
the IL-1R complex (23, 24), inhibited both TLR2- and
IL-1R–mediated NF-kB activation but not induction by
TNF (Fig. 6). Thus, TLR2 stimulation by LPS triggers
an IL-1R–like signaling cascade leading to activation of
NF-kB.
Distribution of TLR2 Transcripts. Expression of TLR2 has
been detected predominantly in peripheral blood leuko-
cytes, spleen, and lung (7, 8). We used RT-PCR to further
analyze TLR2 expression in LPS-responsive cell lines of
monocytic origin. Human THP-1, U937, and Mono-
Figure 3. Analysis of TLR2 deletion mutants. The horizontal bars rep-
resent the sequence of TLR2 with transmembrane domain (TM) and in-
tracellular domain (IC) indicated. The amino acids contained in each de-
letion mutant are stated. 293 cells were transiently cotransfected with
ELAM-1 luciferase reporter plasmid and TLR2 expression vectors (1 mg)
as indicated. After 24 h, cells were either stimulated with LPS (1 mg/ml)
for 6 h or left untreated before harvest. Values shown represent luciferase
activities determined relative to empty vector control.
Figure 4. Serum dependence of TLR2-mediated NF-kB activation by
LPS. 293 cells were transfected with TLR2 expression plasmid (1 mg) and
ELAM-1 luciferase reporter plasmid. After 24 h, cells were stimulated with
the indicated concentrations of LPS for 6 h either in the presence (white
bars) or absence of 10% fetal bovine serum (black bars) before harvest.
Luciferase activities were determined relative to empty vector control.2095 Kirschning et al.
Mac-6 cells were found to express significant levels of
TLR2 mRNA (Fig. 7). In contrast, TLR2 message could
not readily be detected in our LPS-resistant 293 cells (Fig.
7). These results substantiate the requirement for TLR2 in
LPS signaling and are consistent with the profound effects
of LPS on cells of myeloid lineage.
Discussion
The recent identification of several members of a mam-
malian TLR family raised the issue of their functional role
in the vertebrate immune system. In Drosophila, Toll is in-
volved in the rapid and transient transcriptional induction
of several genes encoding potent antimicrobial peptides
upon septic injury (4). Conserved throughout evolution as
innate immunity, this type of activation of nonspecific de-
fense mechanisms by infectious microorganisms uses germ-
line-encoded receptors for the recognition of microbial
pathogens (25). A prominent example of such “pattern rec-
ognition receptors” is CD14, which is activated during the
initial phase of bacterial infection in vertebrates (1, 2). CD14
binds LPS, which possesses a general structure shared by all
Gram-negative bacteria. However, CD14 presumably does
not trigger intracellular signaling events directly, since it
lacks a receptor cytoplasmic domain. The observation that
human TLR4 (hToll) may function in the innate immune
system in vertebrates similar to Toll in Drosophila (6)
prompted us to investigate if members of the mammalian
TLR family might participate in the recognition of bacte-
rial LPS. Our results demonstrate specifically that overex-
pression of TLR2 confers responsiveness to LPS stimula-
tion in mammalian 293 cells. The identification of TLR2 as
a signal transducer for LPS suggests that TLR2 may be a
component of a cellular LPS receptor.
Figure 5. Effect of CD14 on TLR2-mediated NF-kB activation by
LPS. (A) Synergistic activation of NF-kB by coexpression of CD14 and
TLR2. 293 cells were transfected with ELAM-1 luciferase reporter plas-
mid (reference 13) and expression vectors for TLR2 (50 ng) and CD14
(10 ng) as indicated. After 24 h, cells were either left untreated (white bars)
or stimulated for 6 h with LPS at 1 ng/ml (black bars), 10 ng/ml (hatched
bars), and 10 mg/ml (stippled bars) before harvest. Luciferase activities were
determined relative to empty vector control. (B) Effect of purified recom-
binant sCD14 on LPS-induced NF-kB activation by TLR2. 293 cells
were transfected with 200 ng TLR2 expression plasmid and ELAM-1 lu-
ciferase reporter plasmid. After 24 h, cells were left untreated (white bars)
or stimulated for 6 h with LPS at 10 ng/ml (black bars), 100 ng/ml (hatched
bars), or 1 mg/ml (stippled bars) in medium containing either serum or pu-
rified recombinant sCD14 as indicated. Luciferase activities were deter-
mined relative to empty vector control.
Figure 6. Involvement of IL-1 and TNF signaling molecules in TLR2-
mediated NF-kB activation by LPS. 293–IL-1RI cells (reference 14)
were transfected with ELAM-1 luciferase reporter plasmid and expression
vectors (0.3 mg) for TLR2 and dominant-negative mutants of compo-
nents of the IL-1– and TNF-induced NF-kB pathways as indicated. After
24 h, cells were stimulated for 6 h with LPS (10 mg/ml; black bars), IL-1b
(20 ng/ml; hatched bars), or TNF-a (100 ng/ml; white bars) before harvest.
Luciferase values were determined and are expressed as percent activation
for each stimulus relative to cells transfected with TLR2 alone. LPS, IL-1,
and TNF induced 117-, 436-, and 28-fold activation of the reporter gene,
respectively, compared with untreated cells.
Figure 7. TLR2 expression in tis-
sue culture cells. Expression of
TLR2 mRNA in THP-1 (lane 1),
U937 (lane 2), Mono-Mac-6 (lane
3), and 293 cells was analyzed by
PCR after RT (top) or without RT
(middle). RT-PCR analysis of
GAPDH expression was used as
control (bottom).2096 LPS Signaling via Toll-like Receptor 2
The proinflammatory cytokines IL-1 and TNF as well as
bacterial LPS are potent external stimuli regulating the ac-
tivity of NF-kB transcription factors, which control the ex-
pression of numerous immune and inflammatory response
genes (26, 27). Members of the Toll receptor family share
homology in their intracellular portions with the signaling
domains of the IL-1R family, and Drosophila Toll and sev-
eral mammalian TLRs have been shown to activate NF-kB
(3, 6–8). Our mutational analysis of TLR2 illustrates the
importance of the conserved motif of Toll- and IL-1–like
receptors in signaling NF-kB activation. Elucidation of the
NF-kB signaling cascades triggered by TNF and IL-1 has
identified a number of distinct and shared components in
both pathways (28). Our findings indicate that LPS stimu-
lation of TLR2 initiates an IL-1– rather than a TNF-like
NF-kB activation pathway. This is in agreement with Toll
signaling in Drosophila (3). In addition, overexpression of
TLR4 (hToll) in 293 cells, which constitutively activates
NF-kB, was recently found to involve IL-1 signaling com-
ponents (29, 30).
In contrast to CD14, binding studies indicate that TLR2
does not bind LPS with high affinity (our unpublished ob-
servation). Concurrently, we demonstrate that TLR2 sig-
naling requires CD14 to increase LPS sensitivity. Concep-
tually, LPS signal transmission through TLR2 may occur in
a manner analogous to the receptor signaling system used
by glial cell line–derived neurotrophic factor (GDNF), a
member of the TGF-b ligand family. GDNF binds to the
GPI-anchored GDNF receptor a and signals via the trans-
membrane receptor tyrosine kinase, RET, which itself does
not appreciably bind GDNF (31). Alternatively, the puta-
tive cellular LPS receptor may comprise additional compo-
nents, or LPS receptors of distinct composition may exist
on different cell types. Recently, a biophysical model of
LPS action has also been proposed which is dependent on
LPS interactions with membrane lipids and endocytic move-
ment (32). It remains to be investigated if and how TLR2
might participate in such a signaling mechanism. Regard-
less of these considerations, the implication of TLR2 in
LPS signaling supports an important role for the evolution-
ary conserved Toll receptor family in innate immune re-
sponses and provides further insights into the molecular
mechanisms underlying Gram-negative sepsis.
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